neuro42, a Kineticos Portfolio Company, Receives FDA Clearance on Portable and Compact Brain MRI Scanner for Point of Care Imaging…
Kineticos and INCATE join forces in supporting AMR innovators December 6th 2023 – INCATE (the INCubator for Antibacterial Therapies in…
Kineticos Life Sciences Announces Successful Final Close of approximately $60 Million for Kineticos Disruptor Fund II RALEIGH, N.C. | November…
The Kineticos Foundry Building a network of industry partners, key life science executives, and R1 Universities that allow us access…
FastBack Bio is a biotechnology company with a novel CAR-T platform. FastBack Bio will develop CAR-T therapeutics with a novel co-stimulatory domain, M83, from its in-licensed platform.
Promaxo develops and commercializes customer-centric MRI systems and MRI based technologies that enhance patients' lives and redefine the standard of care.
neuro42, Inc. is a medtech Company advancing futuristic technologies for screening, diagnosis, and targeted treatment of neurological conditions.